WuXi PharmaTech (Cayman) Inc.
CIK 0001403132
Revenue (TTM)
—
FY Dec 2014
Net Income (TTM)
$112.16M
−2.1% YoY
FY Dec 2014
EPS Diluted (TTM)
$0.19
−5.0% YoY
FY Dec 2014
Gross Margin
—
FY Dec 2014
Operating Margin
—
FY Dec 2014
Net Margin
—
FY Dec 2014
Free Cash Flow (TTM)
$42.25M
FY Dec 2014
Cash
$211.46M
FY Dec 2014
Total Debt
$203.57M
FY Dec 2014
Shares Outstanding
561.16M sh
FY Dec 2014
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.